Wyoming Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• ACCEL Lite: Dapagliflozin in Patients Undergoing Transcatheter Aortic Valve Implantation
  In this episode, Drs. Allen J. Taylor and Sergio Raposeiras Roubin discuss the safety and clinical benefits of initiating dapagliflozin—or other SGLT-2 inhibitors—in patients undergoing TAVI who are at risk for heart failure, emphasizing its potential to improve outcomes in this high-risk population.
• AZALEA-TIMI 71: Should Abelacimab Be Withdrawn Before Invasive Procedures?
  In patients with atrial fibrillation (AFib) randomized to abelacimab vs. rivaroxaban, no statistically significant differences in bleeding risk were observed, suggesting that interruption of abelacimab treatment may not be necessary before invasive procedures with low bleeding risk...
• The Emergence of Pediatric Sports Cardiology: Highlights From the "Courtside With the Chair" Podcast
  Pediatric sports cardiology is an emerging subspecialty garnering much attention due to devastating reports of exercise-related sudden cardiac arrest and collapse in young athletes.
• ACC CardiaCast: Conversations in Heart Failure: Extrapolate With Caution: A STEMI Shock Reality Check
  In this episode, Drs. Jenna Skowronski, Francesco Castagna and Saraschandra Vallabhajosyula unpack how assumptions drawn from ST-segment elevation myocardial infarction (STEMI) data may be leading us astray in broader shock management.
• Print Publication of ZENITH and SOUL Trials Spark Continued Dialogue
  The print publication of the ZENITH and SOUL trials – originally presented and published online during ACC.25 in Chicago – provides an additional platform for editorial commentary on their broader implication.